CN| EN

Home  > Clinical services  >  BRCA Gene Testing For Breast Cancer  > Advantages

The test makes it possible to achieve early discovery, prevention and intervention of hereditary breast cancer

BRCA1/2 gene test of breast cancer is a program introduced by Annoroad to evaluate risks of breast cancer for the group susceptible to hereditary breast cancer.


Adopting new generation of sequencing technique and bioinformatics analysis, the test can comprehensively detect BRCA1/2 gene mutation and leads to early discovery, prevention and intervention of hereditary breast cancer, thus preventing or slowing down the occurrence and development of breast cancer as well as lowering rates of morbidity and mortality.


1460603206921811.png

 

Copyright2012 Annoroad.com

All rights reserved Annoroad Gene Technology 京ICP备12029022号-1